Two cases of pyogenic spondylitis with chronic hepatitis C during combination therapy of interferon alfa and ribavirin

• SUGAHARA Kazuhiko

  Department of Gastroenterology, Yamagata University School of Medicine

• SAITO Takafumi

  Department of Gastroenterology, Yamagata University School of Medicine

• WATANABE Hisayoshi

  Department of Gastroenterology, Yamagata University School of Medicine

• MISAWA Keiko

  Department of Gastroenterology, Yamagata University School of Medicine

• ISHII Rika

  Department of Gastroenterology, Yamagata University School of Medicine

• SUZUKI Akihiko

  Department of Gastroenterology, Yamagata University School of Medicine

• HAGA Hiroaki

  Department of Gastroenterology, Yamagata University School of Medicine

• SANJO Mai

  Department of Gastroenterology, Yamagata University School of Medicine

• OKUMOTO Kazuo

  Department of Gastroenterology, Yamagata University School of Medicine

• NISHISE Yuko

  Department of Gastroenterology, Yamagata University School of Medicine

• ITO Junitsu

  Department of Gastroenterology, Yamagata University School of Medicine

• SAITO Koji

  Department of Gastroenterology, Yamagata University School of Medicine

• TOGASHI Hitoshi

  Health administration center, Yamagata University School of Medicine

• KAWATA Sumio

  Department of Gastroenterology, Yamagata University School of Medicine

Bibliographic Information

Other Title

• インターフェロン·リバビリン併用療法中に化膿性脊椎炎を 合併したC型慢性肝炎の2例

Abstract

This report describes our experience with two cases of pyogenic spondylitis with chronic hepatitis C during combination therapy of interferon alfa and ribavirin. The first patient, a 59-year-old man, was treated conservatively and improved, but the second patient, a 69-year-old woman, was not improved by conservative therapy and reconstructive operation was performed. The combination therapy of interferon alfa and ribavirin has a high risk of severe infectious diseases as side effects. CT scan and MRI are recommended immediately to diagnose pyogenic spondylitis, when patients has pyrexia and lumbago with laboratory data suspected inflammation during interferon therapy.<br>

Journal

• Nippon Shokakibyo Gakkai Zasshi

  Nippon Shokakibyo Gakkai Zasshi 104 (10), 1519-1525, 2007

  The Japanese Society of Gastroenterology

Keywords

• インターフェロン·リバビリン併用療法
• 化膿性脊椎炎
• 腸腰筋膿瘍

Details

• CRID: 1390001206400899712
• NII Article ID: 10020165111
• NII Book ID: AN00192124
• DOI: 10.11405/nisshoshi.104.1519
• ISSN: 13497693
• ISSN: 04466586
• Web Site: https://search.jamas.or.jp/link/ui/2007347311
• Text Lang: ja
• Data Source:
  • JaLC
  • CiNii Articles
  • KAKEN
• Abstract License Flag: Disallowed